Abbott India Limited Abbott India Limited

Abbott India Limited

ABBOTINDIA

Rangering i aksjer #3023
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Aksjekurs
$284.73
Markedsverdi
$6.05B
Endring (1 dag)
-0.41%
Endring (1 år)
-17.16%
Land
IN
Handel Abbott India Limited (ABBOTINDIA)

Kategori

Healthcare
P/B-forhold for Abbott India Limited (ABBOTINDIA)
P/B-forhold per October 2026 TTM: 11.63
Ifølge Abbott India Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 11.63. Ved slutten av 2024 hadde selskapet et P/B-forhold på 15.81.
P/B-historikk for Abbott India Limited fra 2004 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) 11.63 -23.56%
2025 15.22 -3.74%
2024 15.81 7.52%
2023 14.70 10.22%
2022 13.34 9.03%
2021 12.24 -9.38%
2020 13.50 74.90%
2019 7.72 12.00%
2018 6.89 -3.10%
2017 7.11 -14.94%
2016 8.36 -6.65%
2015 8.96 89.24%
2014 4.73 -2.69%
2012 4.87 -14.72%
2011 5.71 -2.76%
2010 5.87 44.37%
2009 4.06 -22.69%
2008 5.26 1.18%
2007 5.20 3.57%
2006 5.02 -11.95%
2005 5.70 -13.01%
2004 6.55 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
31.9092 174.26%
US
7.3138 -37.14%
US
-84.6033 -827.17%
US
8.6873 -25.33%
US
8.4776 -27.13%
CH